Skip Navigation
Menu
Letters |3 July 2012

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus

Helena W. Rodbard, MD; Paul S. Jellinger, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From Endocrine and Metabolic Consultants, Rockville, MD 20852; and University of Miami, The Center for Diabetes and Endocrine Care, Hollywood, FL 33021.

    Potential Conflicts of Interest: Dr. Rodbard: Consultancy: Novo Nordisk, Amylin, Novartis, Merck; Payment for lectures including service on speakers bureaus: Amylin, Bristol-Myers Squibb, Boehringer Ingelheim, Lilly, Merck, Novo Nordisk, Sanofi. Dr. Jellinger: Consultancy: Amylin, Merck, Novo Nordisk; Payment for lectures including service on speakers bureaus: Amylin, Merck, Novo Nordisk, Boehringer-Ingleheim.

×
FULL TEXT
TO THE EDITOR:
The recently published American College of Physicians (ACP) clinical guidelines for management of patients with diabetes (1) fail to consider algorithms developed by the American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) (2) (for which we served as co-chairs of the task force that developed this algorithm), American Diabetes Association (ADA) (3), Canadian Diabetes Association (4), and Yale Diabetes Center (5). Although these algorithms were developed by specialists, they were specifically intended for use by internists and primary care physicians who treat most patients with type 2 diabetes. The AACE/ACE and ADA algorithms recommend target levels of hemoglobin A1c (HbA1c) to be used for most patients (6.5% and 7.0%, respectively).
FULL TEXT
PDF
Not Available
Citations
Citation

Rodbard HW, Jellinger PS. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus. Ann Intern Med. ;157:75–76. doi: 10.7326/0003-4819-157-1-201207030-00017

Download citation file:

© 2018

×
Permissions

Published: Ann Intern Med. 2012;157(1):75-76.

DOI: 10.7326/0003-4819-157-1-201207030-00017

0 Citations
CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×